✦ LIBER ✦

RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

✍ Scribed by Hervé Bonnefoi; Anil Potti; Mauro Delorenzi; Louis Mauriac; Mario Campone; Michèle Tubiana-Hulin; Thierry Petit; Philippe Rouanet; Jacek Jassem; Emmanuel Blot; Véronique Becette; Pierre Farmer; Sylvie André; Chaitanya R Acharya; Sayan Mukherjee; David Cameron; Jonas Bergh; Joseph R Nevins; Richard D Iggo

Book ID: 117784525
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 397 KB
Volume: 8
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(07)70345-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retraction—validation of gene signatures

Retraction—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

✍ Hervé Bonnefoi; Anil Potti; Mauro Delorenzi; Louis Mauriac; Mario Campone; Michè 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 32 KB

Expression of concern—validation of gene

Expression of concern—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

✍ David Collingridge 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 53 KB

Stroma related gene signature predicts s

✍ H. Bonnefoi; Farmer; V. Becette; M. Piccart; M. Campone; L. Mauriac; J. Jassem; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

5BA Clinical validation of in vitro drug

5BA Clinical validation of in vitro drug sensitivity microarray data: regimen-specific signatures predict pathological complete response to neo-adjuvant chemotherapy for breast cancer in a randomized trial (EORTC 10994/BIG 00-01)

✍ H. Bonnefoi; A. Potti; L. Mauriac; M. Tubiana-Hulin; M. Campone; D. Cameron; J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

A gene expression signature that predict

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy

✍ Yiing Lin; Shin Lin; Mark Watson; Kathryn M. Trinkaus; Sacha Kuo; Michael J. Nau 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 511 KB

TP53 status for prediction of sensitivit

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

✍ Hervé Bonnefoi; Martine Piccart; Jan Bogaerts; Louis Mauriac; Pierre Fumoleau; E 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 405 KB